[A case of lenvatinib therapy-induced unilateral interstitial pneumonia and cavity formation in advanced liver cancer].

Liu, S Q; Zhang, X J; Xue, Y; Lu, J C; Liu, L G

Liu, S Q; Zhang, X J; Xue, Y; Lu, J C; Liu, L G.

Affiliation

Liu SQ; Changzhou School of Clinical Medicine, Nanjing Medical University, Changzhou 213000, China.
Zhang XJ; Changzhou School of Clinical Medicine, Nanjing Medical University, Changzhou 213000, China Changzhou Third People's Hospital, Changzhou 213000, China.
Xue Y; Changzhou School of Clinical Medicine, Nanjing Medical University, Changzhou 213000, China Changzhou Third People's Hospital, Changzhou 213000, China.
Lu JC; Changzhou School of Clinical Medicine, Nanjing Medical University, Changzhou 213000, China Changzhou Third People's Hospital, Changzhou 213000, China.
Liu LG; Changzhou School of Clinical Medicine, Nanjing Medical University, Changzhou 213000, China Changzhou Third People's Hospital, Changzhou 213000, China.

Zhonghua Gan Zang Bing Za Zhi ; 29(11): 1109-1110, 2021 Nov 20.

Article in Zh | MEDLINE | ID: mdl-34933432

Subject(s)

Liver Neoplasms; Lung Diseases, Interstitial; Quinolines; Humans; Liver Neoplasms/drug therapy; Phenylurea Compounds/adverse effects; Quinolines/adverse effects

Key words

Adverse reactions; Interstitial pneumonia; Lenvatinib; Liver cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Lung Diseases, Interstitial / Liver Neoplasms Limits: Humans Language: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Journal subject: GASTROENTEROLOGIA Year: 2021 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google